Correlation Between Cns Pharmaceuticals and Neximmune
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Neximmune, you can compare the effects of market volatilities on Cns Pharmaceuticals and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Neximmune.
Diversification Opportunities for Cns Pharmaceuticals and Neximmune
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cns and Neximmune is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Neximmune go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Neximmune
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Neximmune. In addition to that, Cns Pharmaceuticals is 1.03 times more volatile than Neximmune. It trades about -0.23 of its total potential returns per unit of risk. Neximmune is currently generating about -0.01 per unit of volatility. If you would invest 328.00 in Neximmune on July 26, 2024 and sell it today you would lose (85.00) from holding Neximmune or give up 25.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 44.35% |
Values | Daily Returns |
Cns Pharmaceuticals vs. Neximmune
Performance |
Timeline |
Cns Pharmaceuticals |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cns Pharmaceuticals and Neximmune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cns Pharmaceuticals and Neximmune
The main advantage of trading using opposite Cns Pharmaceuticals and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.Cns Pharmaceuticals vs. PetIQ Inc | Cns Pharmaceuticals vs. Emergent Biosolutions | Cns Pharmaceuticals vs. Bausch Health Companies | Cns Pharmaceuticals vs. Neurocrine Biosciences |
Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |